Frontiers in Clinical Drug Research (Record no. 157664)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02173nam a2200217Ia 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20220322135241.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 210614s9999 xx 000 0 und d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9789811447501 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 2214-7527 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | LC |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Atta-ur-Rahman |
| Relator code | Editor |
| 245 #0 - TITLE STATEMENT | |
| Title | Frontiers in Clinical Drug Research |
| Remainder of title | CNS and Neurological Disorders |
| Statement of responsibility, etc | Atta-ur-Rahman and Zareen Amtul |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc | UAE: |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Name of publisher, distributor, etc | Bentham Science Publisher, |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Date of publication, distribution, etc | 2020. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 215 pages |
| 440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE | |
| Volume number/sequential designation | Vol. 7 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.<br/><br/><br/><br/>The seventh volume of this series features reviews that cover the following topics related to the treatment of neurodegenerative diseases, epilepsy and stroke:<br/><br/>-Fatty Acid Amides as a New Potential Therapeutic Agent in Multiple Sclerosis<br/><br/>-Epileptic Seizures Detection Based on Non-Linear Characteristics Coupled with Machine Learning Techniques<br/><br/>-Hampering Essential Tremor Neurodegeneration in Essential Tremor: Present and Future Directions<br/><br/>-The Potential Therapeutic Role of the Melatoninergic System in Treatment of Epilepsy and Comorbid Depression<br/><br/>-Modeling Neurodegenerative Diseases Using Transgenic Model of Drosophila<br/><br/>-Genetic Basis in Stroke Treatment: Targets of Potent Inhibitors |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Book |
| Source of classification or shelving scheme | Library of Congress Classification |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Library of Congress Classification | Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD) Library | Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD) Library | 22/03/2022 | RM301.27.A88_2020 | P 2976 | 22/03/2022 | 22/03/2022 | Book |